You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allogeneic hematopoietic stem cell transplantation

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Without Crisis Trial in Boston (Plerixafor)

Completed
  • Sickle Cell Disease Without Crisis
  • Boston, Massachusetts
    Boston Childrens Hospital
Jan 23, 2018

Lupus Erythematosus, Systemic Trial in Netherlands (Belimumab Injection)

Recruiting
  • Lupus Erythematosus, Systemic
  • Belimumab Injection
  • Groningen, Netherlands
  • +3 more
Mar 14, 2022

Solid Tumor, Adult Trial in Spain, United States (RBN-2397)

Recruiting
  • Solid Tumor, Adult
  • Aurora, Colorado
  • +14 more
Jul 5, 2022

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Pembrolizumab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 30, 2021

HIV Trial in New York (CPS, SMS)

Completed
  • HIV Infections
  • CPS
  • SMS
  • New York, New York
    The City University of New York
Jul 5, 2022

NSCLC Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Chicago, Illinois
  • +11 more
Aug 31, 2022

Liver Cirrhosis, Biliary Trial in Worldwide (Obeticholic Acid (OCA), Placebo)

Terminated
  • Liver Cirrhosis, Biliary
  • Obeticholic Acid (OCA)
  • Placebo
  • Los Angeles, California
  • +130 more
Jan 14, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +22 more
Aug 16, 2022

NSCLC Trial in Guangzhou (Savolitinib, Placebo)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, China
    Guangdong General Hospital
Nov 29, 2021

Giant Cell Arteritis Trial in Nice

Completed
Has Results
  • Giant Cell Arteritis
    • Nice, Alpes-Maritimes, France
      Hospital of the Archet
    Jul 20, 2022

    Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

    Recruiting
    • Metastatic Lung Small Cell Carcinoma
    • +16 more
    • Phoenix, Arizona
    • +10 more
    Mar 25, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (IOV-2001, Low dose IL-2, High dose IL-2)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • IOV-2001
    • +3 more
    • Tampa, Florida
    • +5 more
    Jan 31, 2022

    Recurrent NSCLC, Stage IV NSCLC Trial in Bay City, Detroit, Port Huron (cytology specimen collection procedure, laboratory

    Recruiting
    • Recurrent Non-small Cell Lung Cancer
    • Stage IV Non-small Cell Lung Cancer
    • cytology specimen collection procedure
    • laboratory biomarker analysis
    • Bay City, Michigan
    • +2 more
    Apr 6, 2022

    Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

    Recruiting
    • Head and Neck Carcinoma of Unknown Primary
    • +5 more
    • External Beam Radiation Therapy
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 1, 2022

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Best Practice
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 14, 2023

    Obesity, Overweight, Weight Loss Trial in Freeport, Hillsboro, Marshall (Weight Management Intervention)

    Active, not recruiting
    • Obesity
    • +2 more
    • Weight Management Intervention
    • Freeport, Illinois
    • +2 more
    Oct 19, 2022

    Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)

    Recruiting
    • Acute Myeloid Leukemia
    • Universal Donor Natural Killer Cells
    • Columbus, Ohio
      Nationwide Children's Hospital
    Aug 11, 2022

    Breast Cancer Trial in Guangzhou (NanoKnife LEDC System)

    Completed
    • Breast Cancer
    • NanoKnife LEDC System
    • Guangzhou, Guangdong, China
      FUDA Cancer Hospital
    Sep 1, 2021

    Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma (MCL)
    • Duarte, California
    • +11 more
    Jul 17, 2023

    Recurrent Ovarian Cancer Trial in Chengdu (dendritic cell)

    Not yet recruiting
    • Recurrent Ovarian Cancer
    • dendritic cell
    • Chengdu, Sichuan, China
      west china second University， SICHUAN University, China
    Feb 25, 2022

    Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Sacramento (Afatinib Dimaleate,

    Completed
    • Recurrent Non-Small Cell Lung Carcinoma
    • +3 more
    • Afatinib Dimaleate
    • Pembrolizumab
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Sep 29, 2021

    Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

    Recruiting
    • Sickle Cell Disease
    • Deferasirox 360 MG
    • Amsterdam, Meibergdreef 9, Netherlands
      Amsterdan UMC location AMC
    May 23, 2022

    Neoadjuvant Therapy Trial in Nanning (tislelizumab combined with axitinib)

    Active, not recruiting
    • Neoadjuvant Therapy
    • tislelizumab combined with axitinib
    • Nanning, Jiangsu, China
      Hongqian Guo
    Dec 13, 2021